NanoViricides, Inc.

1.11 USD
-0.09 (-7.50%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

NanoViricides, Inc. stock is down -2.63% since 30 days ago. The next earnings date is Feb 13, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 26.32% of the previous 18 December’s closed higher than November.

About NanoViricides, Inc.

NanoViricides, Inc. discovers, develops, and commercializes drugs for the treatment of viral infections. Company develops Human Coronavirus Program for COVID-19 seasonal coronavirus affliction. Company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide.